MiR-188-5p is likely to modulate inflammation and c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways by targeting mitogen-activated protein Kinase kinase kinase 3 (MAP3K3) expression, indicating a potential role in CI-AKI [51–53]. This evidence concerns the gene MAPK14 and acute kidney injury.